Viewing Study NCT01737203


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-06-20 @ 2:53 PM
Study NCT ID: NCT01737203
Status: COMPLETED
Last Update Posted: 2021-01-28
First Post: 2012-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Viagra View
None ODT View
None bioquivalence View